# Shanghai Jiaotong University School of Medicine

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/shanghai-jiaotong-university-school-of-medicine
Canonical HTML page: https://getyourbrief.com/entity/shanghai-jiaotong-university-school-of-medicine

## Timeline

- **2026-07-30**: Shanghai Jiaotong University launches investigation — The university forms a working group to comprehensively investigate the clinical trial and the associated Nature paper.
- **2026-07-29**: Joint investigation report published — Science magazine and Retraction Watch release findings detailing the undisclosed death and ethical lapses, bringing the case to public attention.
- **2026-07-26**: University investigation launched — Shanghai Jiao Tong University School of Medicine announces a special working group to investigate and promises 'serious action'.
- **2026-07-23**: Investigative report published — Science and Retraction Watch publish a joint exposé revealing the death and lack of disclosure, triggering international scrutiny.
- **2025**: Mei receives gene-editing therapy — Six-year-old girl with rare cognitive delay condition receives spinal infusion of trillions of engineered viruses in an experimental trial.
- **2025**: Mei dies after therapy — Mei dies approximately one week after the infusion; the death is not reported publicly at the time.
- **2025**: Fatal gene-editing trial conducted — A young girl receives an experimental gene-editing treatment for a developmental-delay-linked genetic defect at Xinhua Hospital; she later dies, an outcome the ethics board deems treatment-related.
- **2018-11**: He Jiankui gene-edited babies scandal breaks — Chinese scientist He Jiankui announces the birth of the world’s first gene-edited babies, triggering global outrage and prompting China to tighten research regulations.

## Recent coverage (2 stories, network-wide)

### Girl's Death in $860K Gene-Editing Trial Prompts Investigation into Chinese Biotech Ethics
2026-08-01 15:53:36 · Sector: bio · Sentiment: Negative · Impact: 7/10 · Sources: 2

A young girl's death in an undisclosed gene-editing trial, funded by $860,000 from her parents, has triggered an investigation at Shanghai Jiaotong University. The case exposes critical ethics gaps in China's surging biopharma sector and raises alarms for investors, partners, and regulators worldwide.
Full story: https://getbiobrief.com/story/girl-death-gene-editing-trial-chinese-biotech

### Gene-Editing Death Rocks Biotech: Trillion-Virus Trial Under Investigation
2026-07-26 14:14:01 · Sector: bio · Sentiment: Strongly negative · Impact: 9/10 · Sources: 2

The death of a young patient in a Chinese gene-editing trial, hidden from a subsequent Nature publication, sends shockwaves through the biotech sector. Industry leaders must grapple with the implications for gene therapy research integrity, funding, and the race to deliver transformative neurological treatments.
Full story: https://getbiobrief.com/story/gene-editing-death-biotech-investigation-ethics

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.